Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Jun 2010. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 59564501000001119 | Revolade | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| 59564601000001115 | Revolade (product) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Revolade | Is a | Trade family | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Revolade 25mg oral powder sachets (Novartis Pharmaceuticals UK Ltd) | Is a | True | Revolade | Inferred relationship | Existential restriction modifier | |
| Revolade 50mg tablets (GlaxoSmithKline UK Ltd) | Is a | True | Revolade | Inferred relationship | Existential restriction modifier | |
| Revolade 25mg tablets (GlaxoSmithKline UK Ltd) | Is a | True | Revolade | Inferred relationship | Existential restriction modifier | |
| Revolade 75mg tablets (Novartis Pharmaceuticals UK Ltd) | Is a | True | Revolade | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR